Tendency to adhere to provider-recommended treatments and subsequent pain severity among individuals with cancer

Patient Preference and Adherence

Volumn 5, Issue , 2011, Pages 23-31

  Jerant, Anthony ^a   Franks, Peter ^a   Tancredi, Daniel J ^a   Saito, Naomi ^a   Kravitz, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Health status; Longitudinal studies; Neoplasms; Outcome assessment (health care)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PAIN; CONTROLLED STUDY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT FORM 12;

EID: 84860702590     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S16236     Document Type: Article

References (48)

1. Fairchild A. Under-treatment of cancer pain. Curr Opin Support Palliat Care. 2010;4(1):11-15
2. Weiss SC, Emanuel LL, Fairclough DL, Emanuel EJ. Understanding the experience of pain in terminally ill patients. Lancet. 2001;357(9265):1311-1315
3. Miaskowski C, Dodd MJ, West C, et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol. 2001;19(23):4275-4279
4. Valeberg BT, Miaskowski C, Hanestad BR, Bjordal K, Moum T, Rustoen T. Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications. Clin J Pain. 2008;24(7):627-636
5. Davis MP, Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care. 2004;21(2): 137-142
6. Ersek M, Kraybill BM, Pen AD. Factors hindering patients' use of medications for cancer pain. Cancer Pract. 1999;7(5):226-232
7. Fitzcharles MA, DaCosta D, Ware MA, Shir Y. Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis. J Pain. 2009;10(3):300-305
8. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002; 40(9):794-811
9. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;16(2):CD000011.
10. Kravitz RL, Tancredi DJ, Street RL Jr, et al. Cancer Health Empowerment for Living without Pain (Ca-HELP): study design and rationale for a tailored education and coaching intervention to enhance care of cancer-related pain. BMC Cancer. 2009;9:319.
11. Street RL Jr, Slee C, Kalauokalani DK, Dean DE, Tancredi DJ, Kravitz RL. Improving physician-patient communication about cancer pain with a tailored education-coaching intervention. Patient Educ Couns. 2010;80(1):42-47
12. Medical Outcomes Study (MOS) measures of patient adherence [homepage on the Internet]. Santa Monica, CA: RAND Corporation, c1994-2010 [updated 2009 Oct 26; cited 2010 Oct 20]. http://www.rand.org/health/surveys_tools/mos/mos_adherence.html. Accessed Jul 20 2010.
13. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med. 1992;15(5):447-468
14. de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9): 1437-1449
15. Green CR, Hart-Johnson T. Cancer pain: an age-based analysis. Pain Med. 2010;11(10):1525-1536
16. Somers TJ, Shelby RA, Keefe FJ, et al. Disease severity and domainspecific arthritis self-efficacy: relationships to pain and functioning in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010; 62(6):848-856
17. Katz J, Poleshuck EL, Andrus CH, et al. Risk factors for acute pain and its persistence following breast cancer surgery. Pain. 2005;119(1-3): 16-25
18. Mosher CE, Duhamel KN, Egert J, Smith MY. Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: associations with barriers to pain management and distress. Clin J Pain. 2010;26(3):227-234
19. Blamey R, Jolly K, Greenfield S, Jobanputra P. Patterns of analgesic use, pain and self-efficacy: a cross-sectional study of patients attending a hospital rheumatology clinic. BMC Musculoskelet Disord. 2009;10:137.
20. Liang SY, Yates P, Edwards H, Tsay SL. Factors influencing opioidtaking self-efficacy and analgesic adherence in Taiwanese outpatients with cancer. Psychooncology. 2008;17(11):1100-1107
21. Thomas E, Silman AJ, Croft PR, Papageorgiou AC, Jayson MI, Macfarlane GJ. Predicting who develops chronic low back pain in primary care: a prospective study. BMJ. 1999;318(7199):1662-1667
22. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209
23. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160(14):2101-2107
24. Sayers SL, Riegel B, Pawlowski S, Coyne JC, Samaha FF. Social support and self-care of patients with heart failure. Ann Behav Med. 2008; 35(1):70-79
25. Holt EW, Muntner P, Joyce CJ, Webber L, Krousel-Wood MA. Healthrelated quality of life and antihypertensive medication adherence among older adults. Age Ageing. 2010;39(4):481-487
26. Chen HF, Tsai YF, Lin YP, Shih MS, Chen JC. The relationships among medicine symptom distress, self-efficacy, patient-provider relationship, and medication compliance in patients with epilepsy. Epilepsy Behav. 2010;19(1):43-49
27. Schousboe JT, Dowd BE, Davison ML, Kane RL. Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures. Osteoporos Int. 2010;21(11):1899-1909
28. Trivedi RB, Ayotte B, Edelman D, Bosworth HB. The association of emotional well-being and marital status with treatment adherence among patients with hypertension. J Behav Med. 2008;31(6):489-497
29. Viswanathan H, Anderson R, Thomas J 3rd. Nature and correlates of SF-12 physical and mental quality of life components among lowincome HIV adults using an HIV service center. Qual Life Res. 2005; 14(4):935-944
30. Platt AB, Localio AR, Brensinger CM, et al. Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf. 2008;17(9):853-860
31. Royal SW, Kidder DP, Patrabansh S, et al. Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV. AIDS Care. 2009;21(4):448-455
32. Unson CG, Litt M, Reisine S, Mahoney-Trella P, Sheperd T, Prestwood K. Adherence to calcium/vitamin D and estrogen protocols among diverse older participants enrolled in a clinical trial. Contemp Clin Trials. 2006;27(3):215-226
33. Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P. Self-report adherence measures in chronic illness: retest reliability and predictive validity. Med Care. 2008;46(11):1134-1139
34. Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology. 2002; 35(3):704-708
35. Cote I, Farris K, Feeny D. Is adherence to drug treatment correlated with health-related quality of life? Qual Life Res. 2003;12(6): 621-633
36. Pavone RM, Burnett KF, LaPerriere A, Perna FM. Social cognitive and physical health determinants of exercise adherence for HIV-1 seropositive, early symptomatic men and women. Int J Behav Med. 1998;5(3):245-258
37. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003;2(3):219-228
38. Zugelj U, Zupancic M, Komidar L, Kenda R, Varda NM, Gregoric A. Self-reported adherence behavior in adolescent hypertensive patients: the role of illness representations and personality. J Pediatr Psychol. 2010;35(9):1049-1060
39. Holstad MM, Foster V, Diiorio C, McCarty F, Teplinskiy I. An examination of the psychometric properties of the Antiretroviral General Adherence Scale (AGAS) in two samples of HIV-infected individuals. J Assoc Nurses AIDS Care. 2010;21(2):162-172
40. McDonnell M, Turner J, Weaver MT. Antecedents of adherence to antituberculosis therapy. Public Health Nurs. 2001;18(6):392-400
41. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993; 31(3):247-263
42. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233
43. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33 Suppl 4: AS264-AS279.
44. Ware JE Jr, Kosinski M, Keller SD. How to score the SF-12 Physical and Mental Health Summary Scales. 3rd ed. Lincoln, RI: QualityMetric, Inc; 1998.
45. Anderson KO, Dowds BN, Pelletz RE, Edwards WT, Peeters- Asdourian C. Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain. Pain. 1995;63(1): 77-84
46. Gelman A, Hill J. Data Analysis using Regression and Multilevel/ Hierarchical Models. New York: Cambridge University Press; 2007.
47. Clogg CC, Petkova E, Haritou A. Statistical methods for comparing regression coefficients between models. Am J Sociol. 1995; 100(5):1261-1293
48. MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci. 2000;1(4): 173-181